• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Medical Device Problem Code Device Markings/Labelling Problem (2911)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/03/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device eval by manufacturer: returned product consisted of an eluvia self-expanding stent system from batch 24285492.The shelf box and device pouch also returned for analysis.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed a kinked to the outer sheath at the nosecone.Microscopic examination revealed no damages.The device pouch label was held over a light and the batch number underneath was visible.Inspection of the remainder of the device revealed no other damage or irregularities.Product analysis confirmed the label underneath has the batch number matching the returned device.
 
Event or Problem Description
It was reported that the stent inside the packaging was the incorrect size.An eluvia drug-eluting vascular stent system was selected for use in a procedure within the superficial femoral artery.The target lesion was approximately 100mm long.During preparation, upon removal from packaging, the device was found to be the incorrect size.The package was labeled 6mm x 100mm, but the stent inside was 6mm x 40mm.The stent appeared shorter than the expected 100mm length, and the handle of the device had 6 x 40 printed on it.It was noted that the inner pouch matched the outer carton/shelf carton.The stent was not implanted.The procedure was completed with another 6mm x 100mm eluvia without issue.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11565996
Report Number2134265-2021-03833
Device Sequence Number11973328
Product Code NIU
UDI-Device Identifier08714729876601
UDI-Public08714729876601
Combination Product (Y/N)Y
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P180011
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2021
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0025838357
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/12/2021
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/03/2021
Initial Report FDA Received Date03/24/2021
Patient Sequence Number1
-
-